Prostate cancer can be detected even in patients with decreased psa less than 2.5 ng/ml after treatment of chronic prostatitis

Korean Journal of Urology

Volumn 52, Issue 7, 2011, Pages 457-460

  Kim, Young Jung ^a   Kim, Sun Ouck ^a   Ryu, Kwang Ho ^a   Hwang, In Sang ^a   Hwang, Eu Chang ^a   Oh, Kyung Jin ^a   Jung, Seung Il ^a   Kang, Taek Won ^a   Kwon, Dong Deuk ^a   Park, Kwangsung ^a   Ryu, Soo Bang ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Biopsy; Prostate specific antigen; Prostatitis

Indexed keywords

CIPROFLOXACIN; PROSTATE SPECIFIC ANTIGEN; ZALTOPROFEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHRONIC INFLAMMATION; CHRONIC PROSTATITIS; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY;

EID: 79961228571     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2011.52.7.457     Document Type: Article

References (18)

1. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
2. Catalona WJ, Ramos CG, Carvalhal GF, Yan Y. Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology 2000;55:791-5.
3. Gilbert SM, Cavallo CB, Kahane H, Lowe FC. Evidence suggesting PSA cutpoint of 2.5 ng/mL for prompting prostate biopsy: review of 36,316 biopsies. Urology 2005;65:549-53.
4. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995;154: 407-13.
5. Carver BS, Bozeman CB, Williams BJ, Venable DD. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003;169:589-91.
6. Potts JM. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000;164:1550-3.
7. Bozeman CB, Carver BS, Eastham JA, Venable DD. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002;167:1723-6.
8. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-81.
9. Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, et al. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005;26:1170-81.
10. Postma R, Schröder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 2005;65:745-9.
11. Anton RC, Kattan MW, Chakraborty S, Wheeler TM. Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol 1999;23:932-6.
12. Ozden C, Ozdal OL, Guzel O, Han O, Seckin S, Memis A. The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis. Int Urol Nephrol 2007;39: 859-63.
13. Erol H, Beder N, Caliskan T, Dündar M, Unsal A, Culhaci N. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies? Urol Int 2006;76:20-6.
14. Kim HW, Ko YH, Kang SH, Lee JG. Predictive factors for prostate cancer in biopsy of patients with prostate-specific antigen levels equal to or less than 4 ng/ml. Korean J Urol 2011;52:166-71.
15. Lee DH, Yang WJ, Chung BH, Kim SI, Kim SJ, Kim YS, et al. A multicenter study of the detection rate for prostate cancer according to the serum prostate-specific antigen level in Korean men. Korean J Urol 2005;46:433-7.
16. Baltaci S, Süer E, Haliloglu AH, Gokce MI, Elhan AH, Bedük Y. Effectiveness of antibiotics given to asymptomatic men for an increased prostate specific antigen. J Urol 2009;181:128-32.
17. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004;350:2239-46.
18. Stopiglia RM, Ferreira U, Silva MM Jr, Matheus WE, Denardi F, Reis LO. Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial. J Urol 2010;183:940-4.